Biotechnology Companies By Working Capital

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Working Capital
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Working CapitalEfficiencyMarket RiskExp Return
1GMAB Genmab AS
22.55 B
 0.06 
 2.01 
 0.12 
2BNTX BioNTech SE
16.28 B
 0.11 
 3.02 
 0.32 
3REGN Regeneron Pharmaceuticals
14.72 B
 0.03 
 3.19 
 0.09 
4GILD Gilead Sciences
7.17 B
 0.13 
 1.93 
 0.25 
5VRTX Vertex Pharmaceuticals
6.03 B
 0.10 
 1.45 
 0.14 
6AMGN Amgen Inc
5.93 B
 0.10 
 1.70 
 0.17 
7MRNA Moderna
5.89 B
 0.08 
 3.56 
 0.29 
8ROIV Roivant Sciences
4.85 B
 0.04 
 1.78 
 0.06 
9ARGX argenx NV ADR
4.21 B
 0.08 
 2.60 
 0.20 
10JAZZ Jazz Pharmaceuticals PLC
3.59 B
 0.14 
 1.65 
 0.23 
11UTHR United Therapeutics
3.14 B
(0.02)
 2.57 
(0.04)
12GLPG Galapagos NV ADR
3 B
 0.21 
 2.07 
 0.44 
13BMRN Biomarin Pharmaceutical
2.63 B
 0.07 
 1.79 
 0.13 
14SRPT Sarepta Therapeutics
2.34 B
(0.08)
 8.82 
(0.75)
15IONS Ionis Pharmaceuticals
2.31 B
 0.22 
 2.15 
 0.46 
16RVMD Revolution Medicines
2.16 B
 0.00 
 2.64 
 0.01 
17RVMDW Revolution Medicines, Warrant
2.16 B
 0.15 
 27.49 
 4.22 
18ALNY Alnylam Pharmaceuticals
2.11 B
 0.25 
 2.88 
 0.71 
19BIIB Biogen Inc
1.93 B
 0.11 
 1.94 
 0.21 
20CRSP Crispr Therapeutics AG
1.85 B
 0.24 
 4.08 
 0.98 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY